Ono type DX Breast Recurrence Score Test

Leeds Teaching Hospitals NHS Trust · Awarded

Buyer
Leeds Teaching Hospitals NHS Trust
Status
Awarded
Country
United Kingdom
Region
EU - Western Europe
Sector
Manufacturing
Reference
UK-CFA-ocds-b5fd17-3205757c-a10d-4c89-8861-ac69b727b6c4
Published
2026-10-26
Deadline
2026-06-30

Tender summary

Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap